AMGA gratefully acknowledges the sponsors of the Accountable Care Organization (ACO) Initiative (as of November 8, 2010).
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the company's web site at www.abbott.com.
Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Japan-based Daiichi Sankyo Co., Ltd., one of the twenty largest pharmaceutical companies in the world and a global leader in pharmaceutical innovation since 1899. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the world.
The primary focus of Daiichi Sankyo's research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also pursuing the discovery of new medicines in the areas of glucose metabolic disorders, infectious diseases, cancer, bone and joint diseases, and immune disorders.
For more information, visit www.dsus.com
Johnson & Johnson Health Care Systems Inc. (JJHCS) provides contracting, supply chain and business services to customers of Johnson & Johnson companies, including hospital systems and group purchasing organizations, health plans, physicians, specialty pharmacy providers, distributors and wholesalers, pharmacy benefits managers, long-term care providers, employers, government payor programs and government health care institutions.